Tivozanib in renal cell carcinoma: a new approach to previously treated disease

por Salgia, Nicholas J., Zengin, Zeynep B., Pal, Sumanta K.
Publicado 2020

Front-Line Therapy for Metastatic Renal Cell Carcinoma: A Perspective on the Current Algorithm and Future Directions

por Govindarajan, Ameish, Castro, Daniela V., Zengin, Zeynep B., Salgia, Sabrina K., Patel, Jalen, Pal, Sumanta K.
Publicado 2022

Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell Carcinoma

por Chehrazi-Raffle, Alexander, Muddasani, Ramya, Dizman, Nazli, Hsu, JoAnn, Meza, Luis, Zengin, Zeynep B., Malhotra, Jasnoor, Chawla, Neal, Dorff, Tanya, Contente-Cuomo, Tania, Dinwiddie, Devin, McDonald, Bradon R., McDaniel, Timothy, Trent, Jeffrey M., Baehner, Frederick L., Murtaza, Muhammed, Pal, Sumanta K.
Publicado 2023

CT-based radiomics model for the prediction of genomic alterations in renal cell carcinoma (RCC)

por Ebrahimi, Hedyeh, Lu, Kun-Han, Castro, Daniela V, Mercier, Benjamin D, Dizman, Nazli, Barragan-Carrillo, Regina, Govindarajan, Ameish, Meza, Luis, Chawla, Neal S, Hsu, JoAnn, Chehrazi-Raffle, Alexander, Tripathi, Abhishek, Liu, Sandy, Dorff, Tanya B, Wah Wong, Chi, Pal, Sumanta K, Zengin, Zeynep B
Publicado 2023